Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.

BDSRA 2015 CLN3 Kielian

915 Aufrufe

Veröffentlicht am

2015 CLN3 Kielian

Veröffentlicht in: Gesundheit & Medizin
  • Loggen Sie sich ein, um Kommentare anzuzeigen.

BDSRA 2015 CLN3 Kielian

  1. 1. Neuroinflammation in Juvenile Batten Disease and the Role of an Anti-inflammatory Treatment Tammy Kielian, Venkata R Kakulavarapu, Megan Bosch, Amy Aldrich, Maria Burkovetskaya, and Nikolay Karpuk Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, 68198, tkielian@unmc.edu KEY PROJECTS WHAT THIS MEANS FOR THERAPY ACKNOWLEDGEMENTS - Forest Laboratories, Inc./Actavis/AstraZeneca - Rachel Fallet and Jessica Odvody for excellent technical assistance - Dr. Jonathan Cooper and Nanet Willumsen- King’s College London - NINDS 1R21NS084392-01A1, Bee For Battens- The Saoirse Foundation INTRODUCTION • Juvenile Batten Disease mainly affects brain function in children severely impairing their behavior, intellectual ability, and day-to-day activities. Brain inflammation has been suggested as being one potential factor contributing to neuron loss in Juvenile Batten Disease. • Several brain cells including microglia, astrocytes, and neurons appear dysfunctional in Juvenile Batten Disease. • Our laboratory’s main focus is to understand how brain inflammation, which is harmful to brain function, occurs in Juvenile Batten Disease. • We use the CLN3∆ex7/8 mouse model of Juvenile Batten Disease in our research and are currently testing the effectiveness of roflumilast, an anti-inflammatory drug, to determine if reducing neuroinflamation can result in slowing disease progression and symptoms. Microglia Astrocytes Neurons • Mouse models of Juvenile Batten Disease display early signs of microglia & astrocyte activation • In mice, microglia and astrocyte activation is apparent within 1-3 months of age; however, neuronal death is significantly delayed in comparison (~ 12 months) • These findings suggest that chronic glial activation and subsequent inflammation may influence neuron survival Morales et al., Front. Cell. Neurosci., 2014 • Microglia protect against foreign insults and clear dead cells/debris in the brain • In response to insults, microglia become activated and produce inflammatory cytokines, such as TNF-a and IL-1b • These inflammatory mediators can have neurotoxic effects, and may contribute to JNCL progression. A B • Figure A shows abnormal cytokine production in CLN3∆ex7/8 microglia that kills neurons • Figure B shows that TNF-a production can be reduced in these microglia when treated with an anti- inflammatory compound • Roflumilast (Daliresp©) is a FDA approved phosphodiesterase-4 (PDE4) inhibitor to reduce the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD) • PDE4 inhibitors have been found in other neurological studies to reduce brain inflammation by inhibiting microglial and astrocyte activation and attenuating microglial proinflammatory cytokine production • We administered Roflumilast to CLN3∆ex7/8 and normal mice orally, once a day, for 6 months starting at 1 month of age • After 3 months of drug treatment, motor function in CLN3∆ex7/8 mice was significantly improved, as indicated by an increased amount of time mice were able to stay on the spinning rotarod • Additionally, astrocyte and microglia activation has been significantly lowered following drug treatment (not shown) • Astrocytes have many functions in the brain and are constantly nurturing neurons to help them function properly • In Juvenile Batten Disease, astrocytes become hyperactive, which can be seen by increased Glial Fibrillary Acidic Protein expression (in green above) • As a result, they do not properly support neurons resulting in neuronal death • Neurons are brain cells that are critically involved in all of our physical and mental activities • Neurons send electrical signals through synapses via specialized structures called axons and dendrites • In Juvenile Batten Disease, some of these neurons die early, which disrupts communication in the brain and eventually leads to cognitive and motor decline Kielian Laboratory • This image shows two different types of synapses, inhibitory and excitatory • In CLN3∆ex7/8 mice , there is an increase in excitatory and decrease in inhibitory synapses • This disrupted ratio can cause neuronal death and seizure activity Inhibitory Excitatory • GFAP, as indicated by the intensity of red staining, is increased in the brains of CLN3∆ex7/8 mice • The Visual Cortex (VC) is responsible for processing information from the eyes • The thalamus (TH) is involved in sleep regulation and is also responsible for relaying sensory and motor signals to other brain regions Overview Rotarod Motor activity